LFAS
ITCI

Level Four Advisory Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Level Four Advisory Services’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,076
Closed -$220K – 915
2024
Q1 		$220K Buy
3,076
+80
+3% +$5.5K 0.01% 696
2023
Q4 		$215K Buy
+2,996
New +$172K 0.01% 701
2023
Q3 		– Sell
-7,483
Closed -$474K – 871
2023
Q2 		$474K Buy
+7,483
New +$466K 0.03% 484
2023
Q1 		– Sell
-7,052
Closed -$373K – 833
2022
Q4 		$373K Sell
7,052
-398
-5% -$19.9K 0.03% 466
2022
Q3 		$347K Sell
7,450
-6,975
-48% -$364K 0.03% 392
2022
Q2 		$823K Sell
14,425
-237
-2% -$13.4K 0.08% 250
2022
Q1 		$897K Buy
+14,662
New +$761K 0.07% 263

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return